Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL1086310 |
|---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| Transient receptor potential cation channel subfamily A member 1 in Rhesus macaque (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6066835] [UniProtKB: A0A1D5QMT1] | ||||||||
| ChEMBL | Antagonist activity at full length rhesus monkey TRPA1 transfected in HEK293F cells assessed as blockade of MO-induced TRPA1 channel activation by measuring Ca2+ influx in presence of 120 uM MO by FLIPR calcium assay | B | 5.14 | pIC50 | 7300 | nM | IC50 | J Pharmacol Exp Ther (2012) 341: 360-368 [PMID:22319196] |
| TRPA1/Transient receptor potential cation channel subfamily A member 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL6007] [GtoPdb: 485] [UniProtKB: O75762] | ||||||||
| ChEMBL | Antagonist activity at human TRPA1 expressed in HEK293 cells assessed as inhibition of CA-induced increase in calcium influx incubated for 10 mins prior to CA addition by Fluo-4-AM dye based fluorescence assayy | B | 4.74 | pIC50 | 18000 | nM | IC50 | Eur J Med Chem (2019) 170: 141-156 [PMID:30878828] |
| ChEMBL | Antagonist activity at human TRPA1 expressed in HEK293 cells assessed as inhibition of CA-induced increase in calcium influx incubated for 10 mins prior to CA addition by Fluo-4-AM dye based fluorescence assayy | B | 4.75 | pIC50 | 17782.79 | nM | IC50 | Eur J Med Chem (2019) 170: 141-156 [PMID:30878828] |
| ChEMBL | Antagonist activity at human TRPA1 expressed in HEK293 cells assessed as inhibition of 5H-dibenzo[b,e]azepine-10-carboxylic acid methyl ester-induced increase in intracellular calcium by Fluo4-AM based fluorometric assay | F | 5 | pIC50 | >10000 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 797-800 [PMID:22222037] |
| ChEMBL | Antagonist activity at human TRPA1 channel expressed in HEK293 cells assessed as inhibition of allyl isothiocyanate-induced intracellular calcium influx by FLIPR | F | 5.12 | pIC50 | 7500 | nM | IC50 | J Med Chem (2010) 53: 5085-5107 [PMID:20356305] |
| ChEMBL | Antagonist activity at full length human TRPA1 transfected in HEK293F cells assessed as blockade of MO-induced TRPA1 channel activation by measuring Ca2+ influx in presence of 30 uM MO by FLIPR calcium assay | B | 5.13 | pIC50 | 7400 | nM | IC50 | J Pharmacol Exp Ther (2012) 341: 360-368 [PMID:22319196] |
| ChEMBL | Antagonist activity at recombinant human TRPA1 expressed in HEK293F cells assessed as reduction in AITC-induced increase in intracellular Ca2+ level by FLIPR-based Ca2+ assay | B | 5.16 | pIC50 | 6900 | nM | IC50 | Pain (2011) 152: 1165-1172 [PMID:21402443] |
| GtoPdb | Calcium imaging | - | 5.2 | pIC50 | - | - | - | Proc Natl Acad Sci USA (2007) 104: 13525-30 [PMID:17686976] |
| ChEMBL | Antagonist activity at human TRPA1 channel assessed as inhibition of allyl isothiocyanate-induced intracellular calcium influx | F | 5.21 | pIC50 | 6200 | nM | IC50 | J Med Chem (2010) 53: 5085-5107 [PMID:20356305] |
| ChEMBL | Inhibition of human TRPA1 expressed in HEK293 cells after 10 mins by FLIPR assay | B | 5.21 | pIC50 | 6200 | nM | IC50 | J Med Chem (2013) 56: 593-624 [PMID:23121096] |
| ChEMBL | Antagonist activity at human TRPA1 expressed in HEK293 cells assessed as inhibition of AITC-induced increase in calcium influx by fluorescence analysis in presence of 5 uM AITC | B | 5.21 | pIC50 | 6200 | nM | IC50 | Eur J Med Chem (2019) 170: 141-156 [PMID:30878828] |
| ChEMBL | Antagonist activity at TRPA1 (unknown origin) | B | 5.21 | pIC50 | 6200 | nM | IC50 | Pain (2011) 152: 1165-1172 [PMID:21402443] |
| ChEMBL | Antagonist activity at human TRPA1 expressed in HEK293 cells assessed as inhibition of allyl isothiocyanate-induced increase in intracellular calcium level incubated for 1 hrs by FLIPR based analysis | B | 5.21 | pIC50 | 6200 | nM | IC50 | Pain (2011) 152: 1165-1172 [PMID:21402443] |
| ChEMBL | Antagonist activity at human TRPA1 channel assessed as inhibition of formalin-induced intracellular calcium influx | F | 5.28 | pIC50 | 5300 | nM | IC50 | J Med Chem (2010) 53: 5085-5107 [PMID:20356305] |
| ChEMBL | Antagonist activity at human TRPA1 channel expressed in HEK293 cells assessed as inhibition of cinnamaldehyde-induced intracellular calcium influx by FLIPR | F | 5.31 | pIC50 | 4900 | nM | IC50 | J Med Chem (2010) 53: 5085-5107 [PMID:20356305] |
| ChEMBL | Antagonist activity at TRPA1 (unknown origin) | B | 5.64 | pIC50 | 2300 | nM | IC50 | J Med Chem (2014) 57: 5129-5140 [PMID:24884675] |
| ChEMBL | Antagonist activity at human TRPA1 expressed in human IMR90 cells assessed as inhibition of acrolein-induced calcium influx after 40 mins by fluorescence analysis | F | 5.74 | pIC50 | 1800 | nM | IC50 | Bioorg Med Chem (2012) 20: 1690-1698 [PMID:22325155] |
| ChEMBL | Antagonist activity at human TRPA1 channel assessed as inhibition of nifedipine-induced intracellular calcium influx | F | 5.74 | pIC50 | 1800 | nM | IC50 | J Med Chem (2010) 53: 5085-5107 [PMID:20356305] |
| TRPA1/Transient receptor potential cation channel subfamily A member 1 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075310] [GtoPdb: 485] [UniProtKB: Q8BLA8] | ||||||||
| ChEMBL | Antagonist activity at full length mouse TRPA1 transfected in HEK293F cells assessed as blockade of MO-induced TRPA1 channel activation by measuring Ca2+ influx in presence of 30 uM MO by FLIPR calcium assay | B | 5.17 | pIC50 | 6800 | nM | IC50 | J Pharmacol Exp Ther (2012) 341: 360-368 [PMID:22319196] |
| TRPA1/Transient receptor potential cation channel subfamily A member 1 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5160] [GtoPdb: 485] [UniProtKB: Q6RI86] | ||||||||
| ChEMBL | Antagonist activity at full length rat TRPA1 transfected in HEK293F cells assessed as blockade of MO-induced TRPA1 channel activation by measuring Ca2+ influx in presence of 30 uM MO by FLIPR calcium assay | B | 5.12 | pIC50 | 7600 | nM | IC50 | J Pharmacol Exp Ther (2012) 341: 360-368 [PMID:22319196] |
| ChEMBL | Antagonist activity at rat TRPA1 expressed in HEK293F cells assessed as reduction in AITC-induced increase in intracellular Ca2+ level by FLIPR-based Ca2+ assay | B | 5.16 | pIC50 | 6900 | nM | IC50 | Pain (2011) 152: 1165-1172 [PMID:21402443] |
| ChEMBL | Antagonist activity at rat TRPA1 expressed in HEK293 cells assessed as inhibition of BITC-induced increase in intracellular calcium concentration by Fluo4-AM based fluorometric assay | F | 5.25 | pIC50 | 5600 | nM | IC50 | Bioorg Med Chem Lett (2012) 22: 797-800 [PMID:22222037] |
| ChEMBL | Antagonist activity at Sprague-Dawley rat TRPA1 expressed in rat DRG neurons assessed as inhibition of acrolein-induced calcium influx after 40 mins by fluorescence analysis | F | 5.68 | pIC50 | 2100 | nM | IC50 | Bioorg Med Chem (2012) 20: 1690-1698 [PMID:22325155] |
| TRPM8/Transient receptor potential cation channel subfamily M member 8 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075319] [GtoPdb: 500] [UniProtKB: Q7Z2W7] | ||||||||
| ChEMBL | Antagonist activity at human TRPM8 channel | F | 4.52 | pIC50 | >30000 | nM | IC50 | J Med Chem (2010) 53: 5085-5107 [PMID:20356305] |
| TRPV1/Transient receptor potential cation channel subfamily V member 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4794] [GtoPdb: 507] [UniProtKB: Q8NER1] | ||||||||
| ChEMBL | Antagonist activity at human TRPV1 channel | F | 4.7 | pIC50 | >20000 | nM | IC50 | J Med Chem (2010) 53: 5085-5107 [PMID:20356305] |
| TRPV3/Transient receptor potential cation channel subfamily V member 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5522] [GtoPdb: 509] [UniProtKB: Q8NET8] | ||||||||
| ChEMBL | Antagonist activity at human TRPV3 channel | F | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2010) 53: 5085-5107 [PMID:20356305] |
| TRPV4/Transient receptor potential cation channel subfamily V member 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3119] [GtoPdb: 510] [UniProtKB: Q9HBA0] | ||||||||
| ChEMBL | Antagonist activity at human TRPV4 channel | F | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2010) 53: 5085-5107 [PMID:20356305] |
ChEMBL data shown on this page come from version 36:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]